112245 ⎘
Vectors comprising a targeting moiety; Vectors comprising as targeting moiety peptide derived from defined protein from viruses; RNA rev transcr viruses Retroviridae
EX VIVO ANTIBODY PRODUCTION
#2METHODS OF DELIVERING ANIONIC AGENTS IN VIVO USING NON-VIRAL NANOPARTICLE-BASED DELIVERY SYSTEMS
#3RNA-based delivery systems with levels of control
#4Methods of delivering anionic agents in vivo using non-viral nanoparticle-based delivery systems
#5Ex vivo antibody production
#6RNA-based delivery systems with levels of control
#7Method of making peptide-tagged PEGylated chitosan nanoparticles
#8Stable Production of Lentiviral Vectors
#9Transgenic VERO-CD4/CCR5 cell line
#10Method of preparing T cells with increased activity
#11Lentiviral vector expressing membrane-anchored or secreted antibody
#12LENTIVIRAL VECTORS AND USES THEREOF
#13NON-VIRAL NANOPARTICLE-BASED DELIVERY SYSTEM
#14Stable production of lentiviral vectors
#15GLUT-1 AS A RECEPTOR FOR HTLV ENVELOPES AND ITS USES
#16Transgenic Vero-CD4/CCR5 cell line
#17Replication-competent VSV-HIV Env vaccines
#18GLUT-1 as a receptor for HTLV envelopes and its uses
#19Baculovirus-based vaccines
#20Lentiviral vectors pseudotyped with mutant BaEV glycoproteins
#21Stable production of lentiviral vectors
#22Hexon Tat-PTD modified adenovirus and uses thereof
#23Retroviral vector particles and methods for their generation and use
#24Chimeric Virus Vaccines
#25ANTISENSE COMPOUND FOR INDUCING IMMUNOLOGICAL TOLERANCE
#26ANTIGEN-SPECIFIC REGULATORY T-CELL INDUCTION
#27Compositions and methods for monosynaptic transport
#28Baculovirus-Based Vaccines
#29Muller Cell Specific Gene Therapy
#30METHODS OF ENHANCING PROTEIN INCORPORATION INTO VIRUS LIKE PARTICLES
#31GLUT-1 as a receptor for HTLV envelopes and its uses
#32Ultrasmall superparamagnetic iron oxide nanoparticles and uses thereof
#33Foamy viral envelope genes
#34Chimeric viral envelopes
#35PATHOTROPIC TARGETED GENE DELIVERY SYSTEM FOR CANCER AND OTHER DISORDERS
#36Antisense compound for inducing immunological tolerance
#37Modified Adenovirus Hexon Protein and Uses Thereof
#38Glut-1 as a receptor for HTLV envelopes and its uses
#39T Cell Line-Based Packaging Cell Line for the Production of Retroviruses by Enriching of Cd3 Expressing Cells
#40Compositions and methods for monosynaptic transport
#41METHOD AND ANTISENSE COMPOSITION FOR SELECTIVE INHIBITION OF HIV INFECTION IN HEMATOPOIETIC CELLS
#42Vector system
#43Viral Particles Containing An Alphavirus-Derived Vector And Method For Preparing Said Viral Particle
#44Cytoplasmic Localization Dna and Rna
#45Cancer cell targeting gene delivery method
#46Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells
#47Vectors
#48Peptide-enhanced transfections
#49CAEV-based vector systems
#50Viral vectors with surface or envelope components
#51Transduction vector based on modified HIV-2
#52Purified polypeptide, isolated nucleic acids encoding said polypeptide, vectors and use thereof
#53Lentiviral vectors and uses thereof
#54Development of a murine model of HIV-1 infection on the basis of construction of EcoHIV, a chimeric, molecular clone of human immunodeficiency virus type 1 and ecotropic moloney murine leukemia virus competent to infect murine cells and mice
#55Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells
#56Intracellular delivery of therapeutic agents
#57Production of infectious hepadnavirus particles containing foamy retrovirus envelope proteins and methods of using the same
#58Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site
#59Compositions and methods for tissue specific targeting of lentivirus vectors
#60Viral uptake into cells and tissues